Minerva Surgical Stock Analysis
| UTRS Stock | USD 0 0.00 0.00% |
Minerva Surgical is overvalued with Real Value of 6.23E-4 and Hype Value of 9.67E-4. The main objective of Minerva Surgical pink sheet analysis is to determine its intrinsic value, which is an estimate of what Minerva Surgical is worth, separate from its market price. There are two main types of Minerva Surgical's stock analysis: fundamental analysis and technical analysis.
The Minerva Surgical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Minerva |
Minerva Pink Sheet Analysis Notes
About 90.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.51. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Minerva Surgical recorded a loss per share of 7.61. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 2nd of October 2023. Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company was incorporated in 2008 and is headquartered in Santa Clara, California. Minerva Surgical operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 157 people.The quote for Minerva Surgical is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call David Clapper at 855 646 7874 or visit https://minervasurgical.com.Minerva Surgical Investment Alerts
| Minerva Surgical is way too risky over 90 days horizon | |
| Minerva Surgical has some characteristics of a very speculative penny stock | |
| Minerva Surgical appears to be risky and price may revert if volatility continues | |
| Minerva Surgical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 50.29 M. Net Loss for the year was (34.11 M) with profit before overhead, payroll, taxes, and interest of 27.24 M. | |
| Minerva Surgical currently holds about 22.39 M in cash with (35.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 90.0% of the company outstanding shares are owned by institutional investors |
Minerva Surgical Upcoming and Recent Events
| 19th of March 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 19th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Minerva Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Minerva Surgical's market, we take the total number of its shares issued and multiply it by Minerva Surgical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Minerva Profitablity
The company has Profit Margin (PM) of (0.65) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.51) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.51.Technical Drivers
As of the 9th of December, Minerva Surgical secures the Mean Deviation of 56.66, standard deviation of 165.57, and Risk Adjusted Performance of 0.1316. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Minerva Surgical, as well as the relationship between them. Please verify Minerva Surgical market risk adjusted performance and treynor ratio to decide if Minerva Surgical is priced some-what accurately, providing market reflects its recent price of 0.001 per share. As Minerva Surgical appears to be a penny stock we also strongly suggest to check its information ratio numbers.Minerva Surgical Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Minerva Surgical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Minerva Surgical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Minerva Surgical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Minerva Surgical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Minerva Surgical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Minerva Surgical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
New Enterprise Associates 13 Lp over a year ago Conversion by New Enterprise Associates 13 Lp of 532333 shares of Minerva Surgical |
Minerva Surgical Outstanding Bonds
Minerva Surgical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Minerva Surgical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Minerva bonds can be classified according to their maturity, which is the date when Minerva Surgical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Minerva Surgical Predictive Daily Indicators
Minerva Surgical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Minerva Surgical pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Minerva Surgical Forecast Models
Minerva Surgical's time-series forecasting models are one of many Minerva Surgical's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Minerva Surgical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Minerva Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Minerva Surgical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Minerva shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Minerva Surgical. By using and applying Minerva Pink Sheet analysis, traders can create a robust methodology for identifying Minerva entry and exit points for their positions.
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company was incorporated in 2008 and is headquartered in Santa Clara, California. Minerva Surgical operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 157 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Minerva Surgical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Additional Tools for Minerva Pink Sheet Analysis
When running Minerva Surgical's price analysis, check to measure Minerva Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Surgical is operating at the current time. Most of Minerva Surgical's value examination focuses on studying past and present price action to predict the probability of Minerva Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Surgical's price. Additionally, you may evaluate how the addition of Minerva Surgical to your portfolios can decrease your overall portfolio volatility.